Cambridge Enterprise is the commercialisation arm of the University of Cambridge, supporting the translation of Cambridge research into global impact through venture building, investment, and academic consultancy. It invests University of Cambridge capital into high-impact, high-growth spin-outs and start-ups.
Deal activity increased 433% year-over-year (16 deals in the last 12 months). Average disclosed round size is $13.5M (across 47 rounds with reported amounts).
Portfolio
88
Fund Size
—
Top Stage
Seed
Last 12 Mo
16
Team
Abigail Swadling
Finance Business Partner
Alessandro Coppola
Assistant Finance Business Partner
Alexandra Canet Font
Communications Director
Annalisa Gigante
External Non-Executive Director
Anthony Odgers
University Non-Executive Director
Ben Alexander
External Non-Executive Director
David Washburn
External Non-Executive Director
Debu Purkayastha
External Non-Executive Director
Dr Dafne Chirivino
Associate Business Development Director (Life Sciences)
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Qkine Ltd | Series A | — | Sep 2026 |
 Houdini Bio | Pre-Seed | $1.9M | Jun 2026 |
 Gigaton | Series A | $26M | Jun 2026 |
 Hacktron | Pre-Seed | $2.9M | May 2026 |
 Hacktron AI | Pre-Seed | $2.9M | May 2026 |
 BioTryp Therapeutics | Seed | — | May 2026 |
 Barocal | Seed | $10M | May 2026 |
 Semarion | Seed | $3.8M | Mar 2026 |
 Immutrin | Series A | $87M | Mar 2026 |
 Seprify AG | Series A | — | Mar 2026 |
 xWatts | Seed | — | Feb 2026 |
 Sparxell | Series A | $5M | Feb 2026 |
 Fluidic | Series A | $31M | Jan 2026 |
 Nu Quantum | Series A | — | Dec 2025 |
 T-Therapeutics | Series A | $91M | Nov 2025 |
 Cambridge Photon Technology | Series A | — | Nov 2025 |
 CamGene Therapeutics | Seed | — | Nov 2025 |
 Trismik | Pre-Seed | — | Sep 2025 |
 Paragraf | Series C | $55M | Aug 2025 |
 Healthera | Series A | — | Apr 2025 |
 TRIMTECH Therapeutics | Seed | $14M | Mar 2025 |
 Cosysense | Pre-Seed | — | Jan 2025 |
| Trismik | Pre-Seed | — | Jan 2025 |
 Echion Technologies | Series B | $35M | Jun 2024 |
| EEchion | Series B | — | Jun 2024 |
Top Co-Investors
Last updated: 7 October 2026